Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-2frpntvPhase 4Not yet recruiting
Phase 4, randomised, double-blind trial of dexamethasone, prednisolone and loteprednol etabonate in cataract (4 arms), sponsored by Instituto para o Desenvolvimento da Educação. Planned start Dec 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-2frpntv.